Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SRx Health Solutions (SRXH) Operating Expenses (2016 - 2025)

Historic Operating Expenses for SRx Health Solutions (SRXH) over the last 16 years, with Q2 2025 value amounting to $20.8 million.

  • SRx Health Solutions' Operating Expenses rose 9408.64% to $20.8 million in Q2 2025 from the same period last year, while for Sep 2025 it was $39.8 million, marking a year-over-year increase of 1461.78%. This contributed to the annual value of $33.0 million for FY2023, which is 3898.31% down from last year.
  • According to the latest figures from Q2 2025, SRx Health Solutions' Operating Expenses is $20.8 million, which was up 9408.64% from $3.5 million recorded in Q1 2025.
  • SRx Health Solutions' 5-year Operating Expenses high stood at $25.8 million for Q4 2022, and its period low was $3.5 million during Q1 2025.
  • Moreover, its 5-year median value for Operating Expenses was $8.5 million (2021), whereas its average is $10.1 million.
  • Per our database at Business Quant, SRx Health Solutions' Operating Expenses crashed by 5730.27% in 2021 and then skyrocketed by 23388.08% in 2022.
  • Over the past 5 years, SRx Health Solutions' Operating Expenses (Quarter) stood at $7.7 million in 2021, then soared by 233.88% to $25.8 million in 2022, then tumbled by 48.66% to $13.3 million in 2023, then grew by 16.79% to $15.5 million in 2024, then surged by 34.62% to $20.8 million in 2025.
  • Its last three reported values are $20.8 million in Q2 2025, $3.5 million for Q1 2025, and $15.5 million during Q4 2024.